These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5254 related articles for article (PubMed ID: 2510384)
1. Modulation by IFN-gamma of the metastatic ability of murine, human, and H-2-transfected tumor cells. Lollini PL; De Giovanni C; Nicoletti G; Scotlandi K; Landuzzi L; Nanni P Tumori; 1989 Aug; 75(4):383-8. PubMed ID: 2510384 [TBL] [Abstract][Full Text] [Related]
2. Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells. De Giovanni C; Palmieri G; Nicoletti G; Landuzzi L; Scotlandi K; Bontadini A; Tazzari PL; Sensi M; Santoni A; Nanni P Int J Cancer; 1991 May; 48(2):270-6. PubMed ID: 1902202 [TBL] [Abstract][Full Text] [Related]
3. Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth. Lollini PL; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Cavallo F; Giovarelli M; Forni G; Modica A; Modesti A Hum Gene Ther; 1995 Jun; 6(6):743-52. PubMed ID: 7548274 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Lollini PL; Bosco MC; Cavallo F; De Giovanni C; Giovarelli M; Landuzzi L; Musiani P; Modesti A; Nicoletti G; Palmieri G Int J Cancer; 1993 Sep; 55(2):320-9. PubMed ID: 8370628 [TBL] [Abstract][Full Text] [Related]
5. Interferon-mediated enhancement of metastasis. Are MHC antigens involved? Lollini PL; De Giovanni C; Del Re B; Nicoletti G; Prodi G; Nanni P Clin Exp Metastasis; 1987; 5(4):277-87. PubMed ID: 3117468 [TBL] [Abstract][Full Text] [Related]
6. Is mts1(S100A4) gene involved in the metastatic process modulated by gamma-interferon? Chiaramonte R; Fasola S; Lollini PL; De Giovanni C; Comi P Pathobiology; 1998; 66(1):38-40. PubMed ID: 9577965 [TBL] [Abstract][Full Text] [Related]
7. Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells. Lauri D; De Giovanni C; Biondelli T; Lalli E; Landuzzi L; Facchini A; Nicoletti G; Nanni P; Dejana E; Lollini PL Br J Cancer; 1993 Nov; 68(5):862-7. PubMed ID: 7692918 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma. Lollini PL; De Giovanni C; Nicoletti G; Bontadini A; Tazzari PL; Landuzzi L; Scotlandi K; Nanni P Clin Exp Metastasis; 1990; 8(2):215-24. PubMed ID: 2107993 [TBL] [Abstract][Full Text] [Related]
9. Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor. Porgador A; Brenner B; Vadai E; Feldman M; Eisenbach L Int J Cancer Suppl; 1991; 6():54-60. PubMed ID: 1906054 [TBL] [Abstract][Full Text] [Related]
10. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs. Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353 [TBL] [Abstract][Full Text] [Related]
11. Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms. Gorelik E; Kim M; Duty L; Henion T; Galili U Clin Exp Metastasis; 1993 Nov; 11(6):439-52. PubMed ID: 8222393 [TBL] [Abstract][Full Text] [Related]
12. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells. Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533 [TBL] [Abstract][Full Text] [Related]
13. IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. Kaido T; Bandu MT; Maury C; Ferrantini M; Belardelli F; Gresser I Int J Cancer; 1995 Jan; 60(2):221-9. PubMed ID: 7829220 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of metastatic potential by gamma-interferon. Kelly SA; Gschmeissner S; East N; Balkwill FR Cancer Res; 1991 Aug; 51(15):4020-7. PubMed ID: 1906780 [TBL] [Abstract][Full Text] [Related]
15. H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules. De Giovanni C; Nicoletti G; Sensi M; Santoni A; Palmieri G; Landuzzi L; Nanni P; Lollini PL Int J Cancer; 1994 Oct; 59(2):269-74. PubMed ID: 7927928 [TBL] [Abstract][Full Text] [Related]
16. H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence. Porgador A; Feldman M; Eisenbach L J Immunogenet; 1989; 16(4-5):291-303. PubMed ID: 2639904 [TBL] [Abstract][Full Text] [Related]
17. Expression of a transfected H-2Kb gene in B16 cells correlates with suppression of liver metastases in triple immunodeficient mice. Calorini L; Marozzi A; Byers HR; Waneck GL; Lee KW; Isselbacher KJ; Gattoni-Celli S Cancer Res; 1992 Jul; 52(14):4036-41. PubMed ID: 1617680 [TBL] [Abstract][Full Text] [Related]
18. Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response. Rozera C; Carlei D; Lollini PL; De Giovanni C; Musiani P; Di Carlo E; Belardelli F; Ferrantini M Am J Pathol; 1999 Apr; 154(4):1211-22. PubMed ID: 10233859 [TBL] [Abstract][Full Text] [Related]
19. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. Plaksin D; Gelber C; Feldman M; Eisenbach L Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4463-7. PubMed ID: 3380801 [TBL] [Abstract][Full Text] [Related]
20. Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells. Nanni P; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Rossi I; Cavallo F; Giovarelli M; Forni G; Lollini PL Br J Cancer; 1996 Nov; 74(10):1564-9. PubMed ID: 8932336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]